BridgeMD
New treatment option for Neuroblastoma
Official title Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
ClinicalTrials.gov ID: NCT06831552
What this study is testing
- What it's testing
- The goal of this study is to test if the addition of a novel income-poverty targeted supportive care intervention (Pediatric Resource Intervention to Support Equity [Pediatric RISE]) to usual supportive care for low-income children with high-risk neuroblastoma can improve parent- and child-centered outcomes. Participants will be randomized to receive one of the following for 6-months: Usual supportive care alone or Usual supportive care plus Pediatric RISE
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 17
You may be able to join if
- Patient cohort: The assigned by chance Phase II multi-center RISE intervention will be conducted among a population of poverty-exposed children with...
- Patient newly diagnosed with high-risk neuroblastoma
- Patient has established care at study site and initiated cancer-directed therapy
- Patient has not yet initiated Induction Cycle 3
- Patient aged 0-17 years at the time of consent
You likely can't join if
- Foreign national family receiving care as an Embassy-pay patient.
- Child or household member receiving SSI
See the full eligibility criteria
- Patient cohort: The assigned by chance Phase II multi-center RISE intervention will be conducted among a population of poverty-exposed children with high-risk neuroblastoma. Poverty will be a priori defined as...
- Patient newly diagnosed with high-risk neuroblastoma
- Patient has established care at study site and initiated cancer-directed therapy
- Patient has not yet initiated Induction Cycle 3
- Patient aged 0-17 years at the time of consent
- Parent/guardian screened positive for self-reported low-income (\<200% Federal Poverty) \
- Family primary residence in MA, PA, IL, CA, WA, CT, GA, WI and OH
- Both patients co-enrolled on ANBL2131 or those receiving standard of care therapy at their center are eligible to participate
- Patients of all languages are eligible to participate
- Foreign national family receiving care as an Embassy-pay patient.
- Child or household member receiving SSI
The study team makes the final eligibility decision.
Where it's taking place
- Hartford, Connecticut, United States
- Atlanta, Georgia, United States
- Boston, Massachusetts, United States
- Philadelphia, Pennsylvania, United States
- Dallas, Texas, United States
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hartford, Connecticut, United States; Atlanta, Georgia, United States; Boston, Massachusetts, United States; Philadelphia, Pennsylvania, United States; Dallas, Texas, United States; Seattle, Washington, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.